Biotech

All Articles

Fierce Biotech Editor-in-Chief Ayla Ellison Speaks Shop with Michelle Benz on the Future of Biotech.

.Let's study a chat with Ayla Ellison, Brutal Biotech Managing Editor and also Michelle Benz as they...

New records show how Bayer's asundexian neglected to avoid strokes

.Bayer put on hold the stage 3 trial for its variable XIa prevention asundexian behind time in 2014 ...

Sanofi's tolebrutinib falls short 2 of 3 late-stage MS tests

.Sanofi is actually still bented on taking its multiple sclerosis (MS) med tolebrutinib to the FDA, ...

Galapagos' stockpile as fund shows intent to mold its evolution

.Galapagos is actually coming under additional tension coming from clients. Having developed a 9.9% ...

Cell- centered Sana gathers very first CSO-- Chutes &amp Ladders

.Invite to today's Chutes &amp Ladders, our roundup of notable leadership hirings, shootings and als...

Allist pays off Jacobio $21M, landing task in Chinese KRAS race

.Shanghai Allist Pharmaceuticals has actually purchased on its own a starring job in China's KRAS ma...

ReNeuron leaving behind AIM exchange after skipping fundraising target

.ReNeuron has participated in the long list of biotechs to leave Greater london's intention stock ma...

MBX apply for IPO to take opposition to Ascendis right into stage 3

.MBX Biosciences has included in the current flurry of IPO filings. The biotech, which submitted its...

FDA expands probing in to Lykos' MDMA tests: WSJ

.For Lykos Therapies and the business's potential MDMA-assisted treatment for trauma (PTSD), the sma...

Gene publisher Volume laying off 131 workers

.Merely days after genetics editor Volume Biosciences revealed unrevealed working cuts, a more clear...